Differential expression of circulating microRNAs in serum: Potential biomarkers to track Japanese encephalitis virus infection. Issue 2 (31st October 2021)

• Record Type: Journal Article
• Authors: Baluni, Manjari; Ghildiyal, Sneha; Fatima, Tanzeem; Tiwari, Rashmi; Upadhyay, Shivbrat; Dhole, Tapan N.; Reddy, D. Himanshu; Singh, Dharamveer
• Is Part Of: Journal of medical virology. Volume 94:Issue 2(2022)
• Page Start: 531
• Page End: 539
• Publication Date: 2021-10-31
• Subjects: acute encephalitis syndrome -- biomarker -- Japanese encephalitis -- micro RNA -- serum; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.27419
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract: Japanese encephalitis is one of the serious vector‐borne viral encephalitis diseases found worldwide and poses a major threat to public health. Most Japanese encephalitis virus (JEV) infections are subclinical; only 1: 250 to 1:1000 infected persons develop clinical presentations. Delay in proper diagnosis of JE affects the timeliness of treatment initiation and increases the mortality rate in patients. Therefore, there is an extreme need to develop potential biomarkers, which might improve the diagnosis and can become the basis for development of new therapeutics. The microRNAs (miRNAs/or miRs) are small noncoding RNAs of 17–24 nucleotides that are known to regulate about 60% of human genes. Although miRNAs have been found to regulate various aspects of innate and adaptive immune responses, less information on circulating miRNAs in JE is known. The study of JEV infected human serum miRNAs will provide novel information for the diagnosis of JE as well as for the improvement of disease outcome. Total RNA, including miRNA, was extracted from serum followed by the complementary DNA (cDNA) synthesis by using sequence‐specific primers. cDNA was amplified using target‐specific TaqMan MicroRNA Assay. Real‐time polymerase chain reaction data was normalized using both exogenous (cel‐miR‐39) and endogenous (hsa‐miR‐93) controls. We have found significantly altered expression of miR‐155 and miR‐21 in serum of JEV infected patients as compared to healthy controls, revealing their role as a a noninvasive biomarker in JE. A significant correlation between miRNAs and JE was observed that offers the basis for miRNAs to serve as a new component to develop possible therapeutic strategies for JE in near future.